GATA2 gene mutation can indicate risk of blood cancers

09/5/2011 | Sydney Morning Herald (Australia), The

Australian researchers have found that mutations in the GATA2 gene could indicate that a person is more vulnerable to developing blood cancers such as myelodysplastic syndrome and acute myeloid leukemia. The gene influences the functions of genes involved in the production of white blood cells. A clinical trial is being undertaken in the U.S. to explore treatment options.

View Full Article in:

Sydney Morning Herald (Australia), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT